Market News / Story
Prostatype Genomics AB (PROGEN) Advances MolDX Review; Nov. Meeting Planned
·
Prostatype Genomics AB submitted additional responses in the MolDX review for Medicare reimbursement of Prostatype and plans a working meeting in the first half of November 2026. Timing of a final decision is not yet known. Material Details #DetailAI Analyst View1Submitted MolDX responsesKeeps the Medicare reimbursement bid active, a key US revenue catalyst if approved.2Nov. working meeting plannedNear-term procedural step that could clarify remaining issues and…